发明名称 |
Induction of IL-12 using immunotherapy |
摘要 |
The present invention relates to compositions and methods that promote the induction of IL-12 in a patient. The composition includes activated allogeneic cells that are administered to a patient with a disease such as cancer. Administration of the composition skews the patient's immune response to a Th1 environment and produces detectable levels of IL-12 in the patient's plasma, without any IL-12 related toxicity.
|
申请公布号 |
US2013101551(A1) |
申请公布日期 |
2013.04.25 |
申请号 |
US201213581745 |
申请日期 |
2012.05.02 |
申请人 |
HAR-NOY MICHAEL;IMMUNOVATIVE THERAPIES LTD. |
发明人 |
HAR-NOY MICHAEL |
分类号 |
A61K39/44;A61K39/385;A61K39/39 |
主分类号 |
A61K39/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|